EA201170121A1 - Лечение инфекций, вызванных антибиотикоустойчивыми бактериями - Google Patents

Лечение инфекций, вызванных антибиотикоустойчивыми бактериями

Info

Publication number
EA201170121A1
EA201170121A1 EA201170121A EA201170121A EA201170121A1 EA 201170121 A1 EA201170121 A1 EA 201170121A1 EA 201170121 A EA201170121 A EA 201170121A EA 201170121 A EA201170121 A EA 201170121A EA 201170121 A1 EA201170121 A1 EA 201170121A1
Authority
EA
Eurasian Patent Office
Prior art keywords
resistant bacteria
infections caused
treatment
antibiotic resistant
bacteria
Prior art date
Application number
EA201170121A
Other languages
English (en)
Other versions
EA018653B1 (ru
Inventor
Мин-чу Хсу
Чи-Син Ричард Кинг
Шу-Цзэнь Чэнь
Люк Линь
Original Assignee
Тайджен Байотекнолоджи Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тайджен Байотекнолоджи Ко., Лтд. filed Critical Тайджен Байотекнолоджи Ко., Лтд.
Publication of EA201170121A1 publication Critical patent/EA201170121A1/ru
Publication of EA018653B1 publication Critical patent/EA018653B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Изобретение относится к способу лечения инфекции, вызванной метициллинустойчивыми бактериями, ванкомицинустойчивыми бактериями, пенициллинустойчивыми бактериями, кларитромицинустойчивыми бактериями или метронидазолустойчивыми бактериями, путем введения субъекту, нуждающемуся в этом, эффективного количества хинолонового соединения формулы, приведенной в описании.
EA201170121A 2008-07-01 2008-09-08 Лечение инфекций, вызванных антибиотикоустойчивыми бактериями EA018653B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7729308P 2008-07-01 2008-07-01
PCT/US2008/075549 WO2010002415A1 (en) 2008-07-01 2008-09-08 Treatment of antibiotic-resistant bacteria infection

Publications (2)

Publication Number Publication Date
EA201170121A1 true EA201170121A1 (ru) 2011-06-30
EA018653B1 EA018653B1 (ru) 2013-09-30

Family

ID=41464848

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201170121A EA018653B1 (ru) 2008-07-01 2008-09-08 Лечение инфекций, вызванных антибиотикоустойчивыми бактериями

Country Status (14)

Country Link
US (1) US8211909B2 (ru)
EP (1) EP2303271B1 (ru)
JP (1) JP2011526887A (ru)
KR (2) KR20110044168A (ru)
CN (1) CN101618038B (ru)
AU (1) AU2008358909B2 (ru)
CA (1) CA2728328C (ru)
EA (1) EA018653B1 (ru)
HK (1) HK1139049A1 (ru)
NZ (1) NZ588898A (ru)
TR (1) TR201820964T4 (ru)
TW (1) TWI375558B (ru)
WO (1) WO2010002415A1 (ru)
ZA (1) ZA201100616B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101392808B1 (ko) * 2011-12-30 2014-05-12 순천대학교 산학협력단 식물 추출물 또는 이의 분획물을 포함하는 항균용 조성물
CN103145615B (zh) * 2013-03-20 2015-07-29 浙江医药股份有限公司 一种奈诺沙星螯合物的后处理方法
KR101392810B1 (ko) * 2013-09-25 2014-05-12 순천대학교 산학협력단 된장풀 추출물 또는 이의 분획물을 포함하는 항균용 조성물
US9492374B2 (en) 2015-03-25 2016-11-15 Jose Rafael Salinas Andrade Composition and method for treatment of ulcers
CN105368825B (zh) * 2015-10-14 2019-09-10 华东医院 幽门螺杆菌抗生素耐药性分析试剂盒及耐药性检测方法
US20200369653A1 (en) * 2017-12-11 2020-11-26 Denovamed Inc. 5-(2,5-bis(4-chloro-2-isopropylphenyl)thiophen-3-yl)-1h-tetrazole for the topical treatment of bacterial infections
CN111979292B (zh) * 2020-07-27 2022-08-05 广东省微生物研究所（广东省微生物分析检测中心） 一种同时携带多重耐药基因cfr和lsa(E)的MRSA的用途
CN114437026A (zh) * 2021-10-26 2022-05-06 浙江医药股份有限公司新昌制药厂 一种低组合物杂质的苹果酸奈诺沙星原料药及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US100800A (en) 1870-03-15 Improvement in riding attachments for plows
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4444762A (en) 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
US6387928B1 (en) * 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
JP4669607B2 (ja) * 1997-09-15 2011-04-13 ザ プロクター アンド ギャンブル カンパニー 抗微生物キノロン類、その組成物およびその使用
US6348624B1 (en) 1998-01-09 2002-02-19 The Procter & Gamble Co. Process for making certain benzoic acid compounds
AU2905702A (en) 2000-12-14 2002-06-24 Procter & Gamble Cyclization process step in the making of quinolones and naphthyridines
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
US6803469B2 (en) 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
WO2005026145A2 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
WO2007110835A2 (en) 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
CA2647457C (en) 2006-03-28 2011-05-24 The Procter & Gamble Company A hydride reduction process for preparing quinolone intermediates
DK2001862T3 (da) * 2006-03-28 2011-08-08 Warner Chilcott Co Llc Malatsalte og polymorfe af (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyklopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolincarboxylsyre
US8658183B2 (en) * 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
US20120157492A1 (en) * 2008-07-15 2012-06-21 Taigen Biotechnology Co., Ltd. Antibiotic drug

Also Published As

Publication number Publication date
CA2728328A1 (en) 2010-01-07
EP2303271A4 (en) 2012-01-25
CN101618038B (zh) 2011-12-07
US8211909B2 (en) 2012-07-03
TWI375558B (en) 2012-11-01
KR20110044168A (ko) 2011-04-28
KR20150006080A (ko) 2015-01-15
TW201002322A (en) 2010-01-16
NZ588898A (en) 2012-09-28
AU2008358909A1 (en) 2010-01-07
EA018653B1 (ru) 2013-09-30
HK1139049A1 (en) 2010-09-10
TR201820964T4 (tr) 2019-01-21
EP2303271A1 (en) 2011-04-06
CA2728328C (en) 2015-02-24
WO2010002415A1 (en) 2010-01-07
CN101618038A (zh) 2010-01-06
EP2303271B1 (en) 2018-11-07
JP2011526887A (ja) 2011-10-20
US20100004282A1 (en) 2010-01-07
ZA201100616B (en) 2011-10-26
AU2008358909B2 (en) 2012-12-13

Similar Documents

Publication Publication Date Title
CY1121701T1 (el) Οργανικες ενωσεις μονοβακταμης για την αντιμετωπιση βακτηριακων λοιμωξεων
EA201170121A1 (ru) Лечение инфекций, вызванных антибиотикоустойчивыми бактериями
NZ708928A (en) Mannose derivatives for treating bacterial infections
CR20110195A (es) Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianas
EA201300860A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
WO2013122888A3 (en) Methods of treating bacterial infections
NZ593111A (en) Antibacterial compounds
AU2012302022A8 (en) Antibacterial compounds and methods for use
EA201000383A1 (ru) Способ ингибирования клостридиум диффициле введением оритаванцина
EA201190095A1 (ru) Производные актагардина
EA200970512A1 (ru) Лечение по поводу множественной миеломы
EA202091676A1 (ru) Способ лечения потери костной массы альвеолярного отростка посредством применения антител к склеростину
EA201591362A1 (ru) Соединения и способы лечения бактериальных инфекций
CL2011001943A1 (es) Terapia antibiotica para tartar o prevenir el sindrome del intestino irritable post- infeccioso.
UA107346C2 (en) Use of nifuratel to treat infections caused by atopobium species
MX2017012073A (es) Compuestos de minociclina para biodefensas.
EA201070504A1 (ru) КАРБАЦЕФЕМ β-ЛАКТАМОВЫЕ АНТИБИОТИКИ
IN2015DN01230A (en) Pyrrolopyrazoles as n type calcium channel blockers
MX2015012472A (es) Derivados de manosa para el tratamiento de infecciones bacterianas.
MA32375B1 (fr) Derives de 5-hydroxymethyl-oxazolidine-2-one pour le traitement de maladies intestinales bacteriennes
WO2011086134A9 (fr) Traitement des infections par les chlamydiaceae par les beta-lactames
MX2009009657A (es) Fluoroquinolonas para el tratamiento, reduccion, mejora, o prevencion de las infecciones provocadas por las bacterias resistentes a los farmacos antibacterianos.
EA201491581A1 (ru) Везикулярные композиции
MX2012004282A (es) Composiciones farmaceuticas.
SG178936A1 (en) Compositions and methods for treating bacterial infections using ceftaroline

Legal Events

Date Code Title Description
QB4A Registration of a licence in a contracting state
QB4A Registration of a licence in a contracting state
QB4A Registration of a licence in a contracting state
QB4A Registration of a licence in a contracting state
QB4A Registration of a licence in a contracting state
QB4A Registration of a licence in a contracting state
TK4A Corrections in published eurasian patents